medicare

A health care company that went public with a SPAC from Chamath Palihapitiya reported quarterly earnings for the first time as a public company Monday. What Happened: Clover Health Investments (NASDAQ: CLOV) reported fourth-quarter revenue of $166.2 million, a year-over-year increase of 44%. Full...

Only two traditional IPO listings are expected to price during the week of March 1. Here is a look at what investors should expect from the IPO offerings. Oscar Health: Health insurance company Oscar Health (NYSE: OSCR) will be the biggest IPO of the week. The health insurance technology...

The IPOs of several insurance companies, such as Lemonade Inc (NYSE: LMND), in 2020 may lead to additional companies in the sector hitting the public market in 2021. Companies could explore a traditional IPO or a SPAC deal to bring their insurance companies public. Oscar Health: Health...

One of Chamath Palihapitiya-backed SPACs merger vote date is Wednesday, Jan. 6. What Happened: Shareholders of Social Capital Hedosophia Holdings Corp III (NYSE: IPOC) will vote on the merger with Medicare Advantage provider Clover Health, valuing the company at $3.7 billion. What’s...

The two largest pharmacy chains in the U.S. have grown through unit expansion and several major acquisitions. The companies have seen their share prices fall on concerns surrounding Amazon.com's entry into the market. Benzinga is looking at how CVS Health Corporation (NYSE: CVS)...

With the 2020 presidential election right around the corner, investors are making predictions on the sectors and stocks that could see big changes. One sector that could change dramatically based on the next occupant of the White House is health care. Potential Winners Under Trump: Hospital...

Chamath Palihapitiya-backed SPAC Social Capital Hedosophia Holdings Corp III (NYSE: IPOC) announced Tuesday that it is bringing Clover Health public at an enterprise valuation of $3.7 billion. Deal Terms: The deal includes $828 million from Social Capital Hedosophia Holdings Corp III...

Gilead Sciences, Inc (NASDAQ: GILD) has agreed to pay $97 million to settle allegations that it illegally paid for Medicare co-pays for its own pulmonary arterial hypertension drug Letairis through a charitable entity. What Happened: The Foster City, California-based drugmaker allegedly used...

Shares of nutrition company MYOS Corporation (NASDAQ: MYOS) were more than doubling Wednesday. The Myos Reverse Merger: Myos announced late Tuesday that it has agreed to a combination with MedAvail, Inc. in a reverse merger. MedAvail is a private, in-clinic, telemedicine-enabled...

President Donald Trump plans to present a $4.8 trillion budget on Monday, which will propose cuts in safety-net programs like Medicare and Medicaid. What Happened Trump’s budget will also propose a 21% cut in foreign aid for fiscal 2021. Reuter’s reports that Trump had tried to cut the...

Davita Inc (NYSE: DVA) surged to all-time highs Friday after winning the praise of a new market advocate. Medicare is largely to thank. The Rating Goldman Sachs analysts led by Stephen Tanal upgraded Davita to Buy and raised their price target from $72 to $97. The Thesis Next year, the U....

Shares of precision dermatology company DermTech Inc (NASDAQ: DMTK) are rallying Thursday after receiving Medicare coverage for its diagnostic test to rule out skin cancer. The California-based company said the Medicare Administrative Contractor Palmetto GBA MolDx issued a final local coverage...

After a year of sector underperformance, several factors are coalescing to make 2020 a better year for the health care sector, Goldman Sachs said Monday as it added three stocks to its conviction list. The Analyst Asad Haider added Amgen, Inc. (NASDAQ: AMGN), UnitedHealth Group Inc (NYSE: UNH...

Mizuho recommended buying three health insurer stocks as it initiated coverage of the sector Thursday.  The Analyst Mizuho's Ann Hynes initiated coverage of Humana Inc. (NYSE: HUM) with a Buy rating and $316 price target.  Hynes started Cigna Corp. (NYSE: CI) with a Buy and...

Plenty of health care exchange traded funds can be dubbed disappointing this year. The iShares U.S. Healthcare Providers ETF (NYSE: IHF) is one fund that belongs in that group. What Happened While IHF's year-to-date gain of 5.88% is tepid at best, the fund's lethargy is not its fault....